Product
SyB C-1101 and Azacytidine
1 clinical trial
1 indication
Indication
Myelodysplastic SyndromeClinical trial
A Phase 1, Open Label, Multicentre Clinical Trial of SyB C-1101 in Combination With Azacytidine in Patients With Myelodysplastic SyndromeStatus: Withdrawn, Estimated PCD: 2017-06-01